DENGAN
DIABETES DAN
HIPERTENSI
PK3 PTO ADVANCE
ANISA MURTI
KELOMPOK F
UNIVERSITAS MUHAMMADIYAH YOGYAKARTA
TOPIK
PEMBAHASAN
1
PENDAHULUAN
2
KASUS
3
ANALIS SOAP
4
REKOMENDASI
PENDAHULUAN
PNEUMONIA
DEFINISI FAKTOR RESIKO
LEVOFLOKSASIN
METOKLOPRAMID
GABAPENTIN
Aberg, J.A., Lacy, C.F., Amstrong, L.L, Goldman, M,P, and Lance,L.L, 2017, Drug Information Handbook, 21
th edition, Lexi-Comp for the Amercan Pharmacist Association.
ADA (American Diabetes Association), 2019. Classification and Diagnosis of Diabetes : Standards of
Medical Care in Diabetes
Anonim, 2023, MIMS Online, https://www.mims.com/indonesia/drug/info. (Diakses, Mei 2023)
Bell K, Twiggs J, Olin BR. Hypertension: The silent killer: updated JNC-8 guideline recommendations.
Alabama Pharmacy Association.
European Heart Journal. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The
Task Force for the management of arterial hypertension of the European Society of Hypertension
(ESH) and of the European Society of Cardiology (ESC)
Perhimpunan Dokter Paru Indonesia (PDPI). Pneumonia Komunitas, pedoman diagnosis &
penatalaksanaan di Indonesia. Jakarta: PDPI, 2003.
Medscape., 2023, Medscape Reference. Aplikasi Medscape. (Diakses 2023)
Menteri Kesehatan Republik Indonesia (2021) Peraturan Menteri kesehatan nomor 28 tahun 2021
Tentang Pedoman Penggunaan Antibiotik. Kementerian kesehatan Republik Indonesia
TERIMAKASIH